Global Liquid Biopsy Market 2018-2024
23-Jun-2018 | Number of pages: 184 | Report Id: BMRC MD 121 | Report Format: | Status: Published

Liquid Biopsy Market By Product Type (Instruments, Kits, Services), By Biomarker Type (Cell-free DNAs, Circulating tumor cells, Exosomes), By Sample Type (Blood, Urine, Serum/Plasma), By Application (Lung Cancer, Leukemia, Gastrointestinal Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer), Industry Analysis, Trends, and Forecast 2018 – 2024

Liquid Biopsy Market: Increasing prevalence of cancer and rising demand for non-invasive procedures are key drivers for Global Liquid Biopsy Market.

Scope of Global Liquid Biopsy Market Reports –

Liquid Biopsy is a unique and non-invasive alternative tool to surgical biopsies and helps in determining an array of information about tumors through a simple test sample. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Liquid Biopsy market, we have considered Liquid Biopsy products and consumables to analyze the market.

Global Liquid Biopsy Market report is segmented on the basis of Product type, Biomarker type, Sample type, Application Type, End User type and by regional & country level. Based on Product type global Liquid Biopsy Market is classified as Instruments, Kits and Services. Based upon Biomarker, global Liquid Biopsy Market is classified as Cell-free DNAs (cfDNAs), Circulating tumor cells (CTCs) and Exosomes. Based upon Sample type, global Liquid Biopsy Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Liquid Biopsy Market is classified as Lung Cancer, Leukemia, Gastrointestinal Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer and others. Based upon End User type, global Liquid Biopsy Market is classified as Hospitals, Diagnostic Laboratories and Cancer Research Centers.

The regions covered in this Liquid Biopsy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Liquid Biopsy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Liquid Biopsy Market Reports-

Global Liquid Biopsy market report covers prominent players like QIAGEN, Adaptive Biotechnologies, Johnson & Johnson, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Cynvenio Biosystems, Inc., Epic Sciences, F. Hoffmann-La Roche Ltd., Genomic Health, Guardant Health, Inc., Illumina Inc., Janssen Diagnostics, MDxHealth, Menarini Silicon Biosystems, Myriad Genetics, Natera Inc., Pathway Genomics Corporation, NeoGenomics Laboratories, Inc., , RainDance Technologies, Inc., Silicon Biosystems, Thermo Fisher Scientific, Trovagene Inc., Sysmex Corporation and others.

Global Liquid Biopsy Market Dynamics –

Increasing number of cancer patients, improvements in diagnostic testing, advancements in immunotherapy and targeted approaches and rising demand of non-invasive diagnostic procedures and personalized medicine

Global Liquid Biopsy Market Regional Analysis –

North America dominates the market with highest market share due to increasing number of cancer incidences and increasing launch of new and advanced products. According to NCI (National Cancer Institute), Increasing prevalence of cancer and increased growth in research and development activities are majorly responsible on growth of Liquid Biopsy market in Europe. According to the  latest report by World Health Organization (WHO), Asia Pacific region anticipates to see a 70% increase in new cancer cases in the next two decades. Asia Pacific Liquid Biopsy Market is witnessed with strong growth rate majorly due high prevalence of cancer, increasing population, growing awareness regarding cure and treatment of cancer and government funding for research and development.

Key Benefits for Global Liquid Biopsy Market Reports –

  • Global Liquid Biopsy Market report covers in depth historical and forecast analysis.
  • Global Liquid Biopsy Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Liquid Biopsy Market report helps to identify opportunities in market place.
  • Global Liquid Biopsy Market report covers extensive analysis of emerging trends and competitive landscape.

Liquid Biopsy Market Segmentation 

By Product Type

  • Instruments
  • Kits
  • Services

By Biomarker Type 

  • Cell-free DNAs (cfDNAs)
  • Circulating tumor cells (CTCs)
  • Exosomes
  • Others

By Sample Type 

  • Blood
  • Urine
  • Serum/Plasma
  • Others

By Application 

  • Lung Cancer
  • Leukemia
  • Gastrointestinal Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

 By End User

  • Hospitals
  • Diagnostic Laboratories
  • Cancer Research Centers

By Region

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Liquid Biopsy Market Key  Players

  • Qiagen
  • Adaptive Biotechnologies
  • Johnson & Johnson
  • Angle Plc.
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Cynvenio Biosystems Inc.
  • Epic Sciences
  • Hoffmann-La Roche Ltd.
  • Genomic Health
  • Guardant Health Inc.

Global Liquid Biopsy Market 2018-2024

Our 184 pages report provides 52 tables, 66 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024, significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Liquid Biopsy Market
  • To receive forecasts of Global Liquid Biopsy sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Liquid Biopsy sector
  • To determine the forces and factor that influences the market for Global Medical Robotics: drivers, restraints, opportunities and threats
  • To find out where the Global Liquid Biopsy Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by region and Country

Global Liquid Biopsy Market: By Region

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

GlobalXXXXXXXXXX
North AmericaXXXXXXXXXX
EuropeXXXXXXXXXX
Asia PacificXXXXXXXXXX
Latin AmericaXXXXXXXXXX
Middle East & AfricaXXXXXXXXXX
GlobalXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Product Type

 2017

(USD Million)

     2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

InstrumentsXX   XX     XXXXXX
KitsXX   XX    XXXXXX
ServicesXX   XX    XXXXXX
TotalXX   XX    XXXXXX
       

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Biomarker Type

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Cell-free DNAs (cfDNAs)XXXXXXXXXX
Circulating tumor cells (CTCsXXXXXXXXXX
ExosomesXXXXXXXXXX
Others
TotalXXXXXXXXXX

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Sample Type

 2017

(USD Million)

     2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

BloodXX   XX     XXXXXX
UrineXX   XX    XXXXXX
Serum/PlasmaXX   XX    XXXXXX
OthersXX   XX     XXXXXX
TotalXX   XX    XXXXXX
       

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Application Type

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Lung CancerXX   XX     XXXXXX
LeukemiaXX   XX      XXXXXX
Gastrointestinal CancerXX   XX      XXXXXX
Breast CancerXX   XX    XXXXXX
Colorectal CancerXX   XX    XXXXXX
Prostate CancerXX   XX    XXXXXX
OthersXX   XX     XXXXXX
Total     XX   XX       XXXX      XX
       

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By End User Type

 2017

(USD Million)

2024

(USD Million)

2017 Market Share (%)CAGR (%)

2018-2024

Consumption

(K Unit)

Hospitals and ClinicsXX   XX     XXXXXX
Diagnostic LaboratoriesXX   XX    XXXXXX
Cancer Research CentersXX   XX    XXXXXX
TotalXX   XX    XXXXXX
       

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey of the Global Liquid Biopsy with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report:

  • Qiagen
  • Adaptive Biotechnologies
  • Johnson & Johnson
  • Angle Plc.
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Cynvenio Biosystems Inc.
  • Epic Sciences
  • Hoffmann-La Roche Ltd.
  • Genomic Health
  • Guardant Health Inc.
  • Illumina Inc.
  • Janssen Diagnostics
  • Mdxhealth
  • Menarini Silicon Biosystems
  • Myriad Genetics, Natera Inc.
  • Pathway Genomics Corporation
  • Neogenomics Laboratories Inc.
  • Raindance Technologies Inc.
  • Silicon Biosystems
  • Thermo Fisher Scientific
  • Trovagene Inc.
  • Sysmex Corporation
  • Others

  • Qiagen
  • Adaptive Biotechnologies
  • Johnson & Johnson
  • Angle Plc.
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Cynvenio Biosystems Inc.
  • Epic Sciences
  • Hoffmann-La Roche Ltd.
  • Genomic Health
  • Guardant Health Inc.
  • Illumina Inc.
  • Janssen Diagnostics
  • Mdxhealth
  • Menarini Silicon Biosystems
  • Myriad Genetics, Natera Inc.
  • Pathway Genomics Corporation
  • Neogenomics Laboratories Inc.
  • Raindance Technologies Inc.
  • Silicon Biosystems
  • Thermo Fisher Scientific
  • Trovagene Inc.
  • Sysmex Corporation
  • Others